Skip to main content
Skip to footer
EQL Pharma Investor Relations
eqlpharma.com
Contact
Svenska
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Shareholders
Analyst
Financial Calendar
List change 2024
Reports
Annual Reports
Interim Reports
Corporate Governance
Management
Board of Directors
Board Committees
Auditor
Nomination Committee
General Meetings
Internal Control and Risk Management
Incentive programs
Articles of Association
Media
Press Releases
Presentations
About Us
IR Contact
Vision
Mission
Business Concept
Business Model
Objectives
The Share
Shareholders
Analyst
Financial Calendar
List change 2024
Reports
Annual Reports
Interim Reports
Corporate Governance
Management
Board of Directors
Board Committees
Auditor
Nomination Committee
General Meetings
Internal Control and Risk Management
Incentive programs
Articles of Association
Media
Press Releases
Presentations
Reports
Here you can read our latest reports
Read More
Annual Reports
Annual Report 2023/2024
Read Here
Annual Report 2022/2023
Read Here
Annual Report 2021/2022
Read Here
Se all
Interim Reports
Interim Report Q2 2024/2025
Interim Report Q1 2024/2025
Year End Report 2023/2024
Interim Report Q3 2023/2024
Interim Report Q2 2023/2024
Se all
Interim Report Q2 2024/2025
Listen to CEO Axel Schörling present EQL Pharma's latest report.
Se all
Upcoming reports
05
Feb
2025
Interim Report Q3
08
May
2025
Year End Report Q4
